Shop all of Dima's products

Filter by

Melaz-K Cream – Hyperpigmentation & Melasma Treatment

P 650.00

Melaz-K Cream: Target hyperpigmentation and melasma with this powerful cream containing kojic acid dipalmitate, arbutin, and vitamin C for a brighter and more even skin tone.

 

Out of Stock

Melaz-K Cream – Hyperpigmentation & Melasma Treatment

P 650.00

Description
  • Melaz-K Cream is a specialized formulation designed to address hyperpigmentation and melasma concerns. With its powerful blend of ingredients such as kojic acid dipalmitate, arbutin, and vitamin C, this cream helps reduce melanin production, promote collagen synthesis, and lighten the skin. Regular use of Melaz-K Cream can contribute to a more even skin tone and diminished appearance of dark spots, providing you with a brighter and more radiant complexion.
Reviews (0)

Melaz-K Cream is specifically formulated for the treatment of hyperpigmentation and melasma, helping to reduce the appearance of dark spots and uneven skin tone.

This cream contains kojic acid dipalmitate, which is known to be more effective than plain kojic acid in inhibiting tyrosinase activity, a key enzyme involved in melanin production. Additionally, vitamin C promotes collagen synthesis and helps suppress skin pigmentation, while arbutin acts as a natural skin lightener.

For best results, apply a thin layer of the cream to the affected areas of the skin twice daily, in the morning and evening. Gently massage it into the skin until fully absorbed.

While the cream is generally well-tolerated, it is always recommended to perform a patch test before using it on sensitive skin. If any irritation or discomfort occurs, discontinue use and consult a dermatologist.

The timeline for noticeable results may vary from person to person. It is important to be consistent with the application and allow sufficient time for the product to work. Significant improvement in hyperpigmentation and melasma may be seen after several weeks of regular use.

We love to hear from you!

WRITE A REVIEW